Get the Stockscreener App
6.25
1.13%
0.07
Immucell Corp stock is traded at $6.25, with a volume of 106.21K.
It is up +1.13% in the last 24 hours and down -2.34% over the past month.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
See More
Previous Close:
$6.18
Open:
$6.25
24h Volume:
106.21K
Relative Volume:
8.62
Market Cap:
$56.54M
Revenue:
$23.84M
Net Income/Loss:
$-3.81M
P/E Ratio:
-12.50
EPS:
-0.5
Net Cash Flow:
$-713.00K
1W Performance:
+0.81%
1M Performance:
-2.34%
6M Performance:
+30.48%
1Y Performance:
+72.18%
1-Day Range:
$6.00
$6.70
1-Week Range:
$5.7151
$6.70
52-Week Range:
$3.38
$7.60
Immucell Corp Stock (ICCC) Company Profile
Name
Immucell Corp
Sector
Industry
Phone
(207) 878-2770
Address
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.25 | 55.90M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Immucell Corp Stock (ICCC) Latest News
Is ImmuCell Corporation a good long term investmentCandlestick Pattern Analysis & Get The Analyst Consensus With One Click - earlytimes.in
What is the fair value estimate for ImmuCell Corporation (IUL) stock in 2025Portfolio Performance Report & Entry Point Confirmation Signals - newser.com
Is a relief rally coming for ImmuCell Corporation holdersTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
ImmuCell names Olivier te Boekhorst as new president and CEO - Investing.com
ImmuCell Announces Selection of its Next President and CEO - MarketScreener
ImmuCell Corporation Appoints Olivier te Boekhorst as President, Effective November 1, 2025 - MarketScreener
Developing predictive dashboards with ImmuCell Corporation dataJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
Best data tools to analyze ImmuCell Corporation stockTrade Analysis Report & Growth Oriented Trade Recommendations - newser.com
Technical analysis overview for ImmuCell Corporation stock2025 Performance Recap & Entry Point Strategy Guides - newser.com
What indicators show strength in ImmuCell Corporation2025 Volatility Report & Consistent Growth Stock Picks - newser.com
Will ImmuCell Corporation continue its uptrendWeekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
Is ImmuCell Corporation stock a dividend growth opportunityPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com
Why ImmuCell Corporation (IUL) stock is listed among top recommendationsWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Chart overlay techniques for tracking ImmuCell CorporationMarket Growth Summary & Technical Pattern Based Signals - newser.com
ImmuCell (NASDAQ:ICCC) Share Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Published on: 2025-09-20 13:32:32 - خودرو بانک
Real time alert setup for ImmuCell Corporation performance2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Stock Analysis: Does ImmuCell Corporation have a sustainable dividend2025 Macro Impact & Verified Entry Point Detection - خودرو بانک
What candlestick patterns are forming on ImmuCell CorporationShort Setup & Real-Time Chart Breakout Alerts - newser.com
Investment Review: Will ImmuCell Corporation benefit from AI trendsEarnings Growth Summary & Weekly High Return Stock Opportunities - khodrobank.com
Investment Recap: Is ImmuCell Corporation a speculative investmentPortfolio Update Report & Consistent Profit Alerts - خودرو بانک
Is ImmuCell Corporation still worth holding after the dip2025 Short Interest & Growth Focused Entry Point Reports - newser.com
Smart tools for monitoring ImmuCell Corporation’s price actionMarket Rally & Reliable Breakout Forecasts - newser.com
Predicting ImmuCell Corporation trend using moving averagesTrend Reversal & Capital Protection Trade Alerts - newser.com
ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Does ImmuCell Corporation show high probability of reboundJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com
Aug PreEarnings: Will ImmuCell Corporation benefit from geopolitical trendsQuarterly Market Summary & Precise Swing Trade Entry Alerts - خودرو بانک
Weekly Trades: Is ImmuCell Corporation vulnerable to short sellersRate Hike & Weekly Breakout Opportunity Watchlist - خودرو بانک
Revenue Check: Is ImmuCell Corporation forming a bullish divergenceWeekly Gains Report & Technical Buy Zone Confirmations - خودرو بانک
How moving averages guide ImmuCell Corporation tradingBond Market & Safe Capital Growth Tips - newser.com
how moving averages guide immucell corporation tradingWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Immucell Corp Stock (ICCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):